Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance Study To Observe Safety And Effectiveness Of Eraxis (Registered) Iv.

NCT00802854 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00802854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00802854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance Study To Observe Safety And Effectiveness Of Eraxis (Registered) Iv.
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
March 2, 2012
Completion date
May 20, 2016
Enrollment
244 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

candidemia, other forms of candida infections(intra-abdominal abscess, peritonitis)